본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

백혈병세포에서 PTEN 발현에 대한 Ciglitazone과 retinoic Acid의 항진 작용
Ciglitazone, in Combination with All trans Retinoic Acid, Synergistically Induces PTEN Expression in HL-60 Cells

이성호    (공주대학교 영상보건대학 간호학과   ); 박철홍    (전북대학교 의과대학 생화학교실 의과학연구소   ); 김병수    (공주대학교 산업과학대학 특수동물학과  );
  • 초록

    Peroxisome proliferator-activated receptor-gamma $(PPAR{\gamma})$ 는 DNA와 결합하기 위해 retinoid-X receptor(RXR)와 heterodimer를 형성해야만 한다. 그리고 전사에 대한 최대활성은 수용체에 대한 리간드 특이성에 의하는 것으로 생각되고 있다. 활성화된 $(PPAR{\gamma})$ 와 $(PPAR{\gamma})$ 리간드는 종양억제 PTEN의 조절을 통해 종양세포의 성장에 영향을 끼치게 된다. 본 연구의 목적은 $(PPAR{\gamma})$ ligand, ciglitazone그리고 RXR ligand로 동시에 자극하였을 때 급성전골수성백혈병(APL) 세포에 대해 이들이 함께 PTEN upregulate를 조절할 수 있는지를 결정하기 위함이다. 그리고 이들 세포의 성장과 분화주기에 대해 강력한 억제 능이 있는지를 결정하고자 하였다. 즉, 사람의 백혈병세포주인 HL-60세포에 all-trans-retinol과 ciglutazone을 노출시킨 뒤 PTEN 발현에 대한 측정을 위해 RT-PCR법으로 PTEN mRNA 발현 정도를 확인하고 western blot으로 분석하였다 세포주기의 분석은 propidium iodide(PI) 염색법과 FACScan으로 분석하였고, HL-60 cells에서 $(PPAR{\gamma})$ ligand, ciglitazone, 그리고 RXR ligand, retinoic acid 그리고 upregulated PTEN 발현에 대한 time- and dose-dependent방법으로 각각 확인하였던 바 ciglitazone과 retinoic acid를 동시 조합하여 처치하였을 때 유의적인 효과를 인정할 수 있었다. 더욱이 이들 혼합 물질은 세포의 성장과 G, phase를 동시 억제하는 능력이 있었다. 그러므로 $(PPAR{\gamma})$ 의 활성에 있어 RXR heterodimer가 사람의 백혈병세포에 대한 조절 경로로서 존재하며, PTEN의 upregulation을 통해 백혈병을 조절하기 때문에 백혈병의 예방 및 치료 접근에 $(PPAR{\gamma})$ 와 RXR ligands가 중요한 역할을 할 것이다.


    Peroxisome proliferatorr-activated receptor-gamma $(PPAR{\gamma})$ must form a heterodimer with the retinoid-X receptor (RXR) to bind DNA, and its transcriptional activity is thought to be maximized by ligands specific for either receptor. Activated $(PPAR{\gamma})$ and $(PPAR{\gamma})$ ligands may influence tumor growth through regulation of the tumor suppressor PTEN. Our aim in this study was to determine whether co-stimulation with the $(PPAR{\gamma})$ ligand, ciglitazone, and RXR ligand can synergistically upregulate PTEN in human acute promyelocytic leukemia (APL) cells and consequently potentate the inhibition of cell growth and cell cycle progression of these cells. Human leukemia cell line, HL-60 cells were exposed to all-trans-retinol and ciglutazone. The PTEN expression was measured as the level of PTEN mRNA expression by RT-PCR and as the level of PTEN expression by western blot analysis. Cell cycle analysis was carried out by a propidium iodide (PI) staining method and analyzed with a FACScan. The $(PPAR{\gamma})$ ligand, ciglitazone, and the RXR ligand, retinoic acid, upregulated PTEN expression by HL-60 cells in time- and dose-dependent manners, respectively. This was significantly enhanced by a combination of both ciglitazone and retinoic acid. Moreover, these compounds synergistically induced arrests of both cell growth and the $G_l$ phase of the cell cycle. Thus, the activation of the $(PPAR{\gamma})$ :RXR heterodimer may represent a regulatory pathway for human leukemia cells and there may be important roles for $(PPAR{\gamma})$ and RXR ligands in prophylactic and therapeutic approaches fur controlling leukemia through the upregulation of PTEN.


  • 주제어

    PTEN .   $(PPAR{\gamma})$ .   retinoid-X receptor .   leukemia .   ciglitazone .   retinoic acid.  

  • 참고문헌 (49)

    1. Myers, M.P., Pass, I., and Batty, I.H. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. U. S. A. 95, 13513-13518 (1998) 
    2. Li, J., Yen, C., and Liaw, D. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997) 
    3. Teng, D.H., Hu, R., Lin, H. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221-5225 (1997) 
    4. Sakai, A., Thieblemont, C., and Wellmann, A. PTEN gene alterations in lymphoid neoplasms. Blood 92, 3410-3415 (1998) 
    5. Dahia, PL, Aguiar, RC, and Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum. Mol. Genet. 8, 185-193 (1999) 
    6. Rosen, E.D., and Spiegelman, B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731-37734 (2001) 
    7. Lehmann, J.M., Lenhard, J.M, and Oliver, B.B. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410 (1997) 
    8. Tontonoz, P., Singer S., and Forman, B.M. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc. Natl. Acad. Sci. U. S. A. 94, 237-241 (1997) 
    9. Tontonoz, P., Nagy, L., and Alvarez, J.G. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252 (1998) 
    10. Asou, H., Verbeek, W., and Williamson, E. Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids. Int. J. Oncol. 15, 1027-1031 (1999) 
    11. Cornic, M., Delva, L, and Guidez, F. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res. 52, 3329-3334 (1992) 
    12. Witcher, M., Shiu, H.Y., Guo, Q., Miller, WH, Jr. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acidresistant acute promyelocytic leukemia cells. Blood 104, 3335-3342 (2004) 
    13. Mukherjee, R, Davies, PJ, Crombie, DL. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386, 407-410 (1997) 
    14. Yang, Z., Bagheri-Yarmand, R., and Balasenthil, S. HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy. Clin. Cancer Res. 9, 3198-3203 (2003) 
    15. Moore, K.J., Rosen, E.D., and Fitzgerald, M.L. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7, 41-47 (2001) 
    16. Gallagher, RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 16, 1940-1958 (2002) 
    17. Liu, T.C., Lin, P.M., and Chang, J.G.. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am. J. Hemato. 63, 170-175 (2000) 
    18. Wightman, J., Roberson, M.S., Lamkin, T.J. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle. Mol. Cancer Ther. 1, 493-506, (2002) 
    19. Stambolic, V., Suzuki, A., and de la Pompa, J.L. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998) 
    20. Barbui, T., Finazzi, G., and Falanga, A. The impact of alltrans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 91, 3093-3102 (1998) 
    21. Suh, N., Wang, Y., and Honda, T. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res. 59, 336-341 (1999) 
    22. Seminario, M.C., Precht, P. Wersto, R.P., Gorospe, M., and Wange, R.L. PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression. Oncogene 22, 8195-8204 (2003) 
    23. Lee, YR, Shim, HJ, and Yu, H.N. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-kappa B activation in HL-60 cells. Leuk. Res. 29, 401-405 (2005) 
    24. Obata, K., Morland, S.J., and Watson, R.H. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095-2097 (1998) 
    25. Willson, T.M., Lambert, M.H, and Kliewer, S.A. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 70, 341-367 (2001) 
    26. Cantley, L.C., and Neel, B.G.. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad .Sci. U. S. A. 96, 4240-4245 (1999) 
    27. Wen, S., Stolarov, J., and Myers, M.P. PTEN controls tumor-induced angiogenesis. Proc Natl. Acad.Sci. U. S. A. 98, 4622-4627 (2001) 
    28. Konopleva, M., and Andreeff, M.. Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies. Curr. Opin. Hematol. 9, 294-302 (2002) 
    29. Hwang, P.H., Yi, H.K, Kim, D.S., Nam, S.Y., Kim, J.S., and Lee, DY. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene. Cancer Lett. 172, 83-91 (2001) 
    30. Kim, J.S., Peng, X., De, P.K. PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. Blood 99, 694-697 (2002) 
    31. Demetri, G.D., Fletcher, C.D., and Mueller, E. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc. Natl. Acad. Sci. U. S. A. 96, 3951-3956 (1999) 
    32. Brown, G, Bunce, CM, Rowlands, DC, et al. All-trans retinoic acid and 1 alpha, 25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia 8, 806-815 (1994) 
    33. Nolte, RT, Wisely, GB, Westin, S. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395, 137-143 (1998) 
    34. Patel, L, Pass, I, Coxon, P. Tumor suppressor and antiinflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr. Biol. 11, 764-768 (2001) 
    35. Kwak, Y.G., Song, C.H., Yi, H.K. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111, 1083-1092 (2003) 
    36. Denzlinger, C. D.K, and Mohle, A. Peroxisom proliperator activated receptor g (PPAR${\gamma}$) agonist as antileukemic agents in CMML. Blood 98, 625a (2001) 
    37. Di Cristofano, A., and Pandolfi, P.P. The multiple roles of PTEN in tumor suppression. Cell 100, 387-390 (2000) 
    38. Li, Y., Dawson, M.I., and Agadir, A. Regulation of RAR beta expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int. J. Cancer. 75, 88-95 (1998) 
    39. Vlietstra, R.J., van Alewijk, D.C., Hermans, K.G., van Steenbrugge, G.J., and Trapman, J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 58, 2720-2723 (1998) 
    40. Warrell, RP, Jr., de The, H, Wang, ZY, and Degos, L. Acute promyelocytic leukemia. N. Engl. J. Med. 329, 177-189 (1993) 
    41. Konopleva, M., Tsao, T., and Ruvolo, P. Novel triter penoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood 99, 326-335 (2002) 
    42. Warrell, RP, Jr., Frankel, SR, and Miller, W.H. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324, 1385-1393 (1991) 
    43. Santos, N.C., Martins-Silva, J., and Saldanha, C. PTEN 'meets' DMSO. Leuk. Res. 29, 361-362 (2005) 
    44. Hisatake, J, O'Kelly, J, Uskokovic, MR, Tomoyasu, S, Koeffler, HP. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 97, 2427-2433 (2001) 
    45. Breitman, T.R., Selonick, S.E., and Collins, S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U. S. A. 77, 2936-2940 (1980) 
    46. Olsson, I.L., and Breitman, T.R. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents. Cancer Res. 42, 3924-3927 (1982) 
    47. Koeffler, H.P. Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res. 9, 1-9 (2003) 
    48. Cappellini, A., Tabellini, G., and Zweyer, M. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Leukemia 17, 2157-2167 (2003) 
    49. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman R.A., and Evans, R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774 (1992) 

 저자의 다른 논문

  • 이성호 (17)

    1. 2001 "개의 전침마취에 관한 연구 2. 배부혈위의 효과에 대한 검토" Journal of veterinary clinics = 한국임상수의학회지 18 (4): 311~314    
    2. 2002 "돼지에서 동결정액을 이용한 인공수정시 종모돈의 품종, 인공수정 횟수, 정자농도, 농장 및 연도가 번식성적에 미치는 영향" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 26 (2): 111~117    
    3. 2002 "동결정액 포장방법이 돼지정액의 성상 및 번식성적에 미치는 영향" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 26 (2): 119~124    
    4. 2003 "한우 섬유아세포의 성 판별 및 세포주기 유도 분석" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 27 (1): 53~59    
    5. 2003 "첫 발정과 종부시 체중, 연령, 체형, 등지방 두께 및 스테로이드 호르몬 농도에 미치는 종빈돈 품종의 영향" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 27 (2): 163~167    
    6. 2003 "면역결핍동물의 생산을 위한 형질전환생쥐의 분석" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 27 (2): 179~185    
    7. 2003 "CHO 세포와 형질전환 닭에 있어서 Retrovirus Vector System에 의한 hFSH 재조합 유전자의 전이와 발현" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 27 (3): 197~206    
    8. 2003 "형질전환생쥐에서 Lck Promoter에 의한 Diphtheria Toxin-A Gene의 발현 분석" 韓國家畜繁殖學會誌 = Korean journal of animal reproduction 27 (3): 225~231    
    9. 2005 "진도개의 체형 - 몸통과 다리" 한국동물자원과학회지 = Journal of animal science and technology 47 (5): 891~898    
    10. 2006 "면역기능 증강성 신물질에 대한 돼지에서의 면역 증강성 실험" 한국식품위생안전성학회지 = Journal of food hygiene and safety 21 (2): 113~117    
  • 박철홍 (1)

  • 김병수 (23)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 이용한 콘텐츠
이 논문과 함께 출판된 논문 + 더보기